Clinical Trial Update: MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV [Phase 4]

View source ↗

Summary

A Phase 4 multicenter trial (MASCOT) evaluating adjuvant oxaliplatin/5-FU-leucovorin in colon cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Colonic Neoplasms | Phase 4 | Status: COMPLETED